The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
45 Milton Road
LONDON, W7 1LQ United Kingdom
0800 028 4447
The Arthrogryposis Group (AG) is a non-profit voluntary health organization dedicated to offering contact, information, and support to people with arthrogryposis and their families. Arthrogryposis is a non-progressive condition that limits range of movement in the joints and is accompanied by muscle weakness. Established in 1984, the organization provides information to professionals and other interested parties, encourages public awareness, and furthers research in the field. In addition, the organization sponsors regional events, activity camps, and annual conferences for all families, Group members, and other interested individuals. Educational materials produced and distributed by the organization include a quarterly newsletter, a documentary video, brochures, and an authoritative booklet.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.